EASD 2024: Insights on Heart Failure with Preserved Ejection Fraction (HFpEF) @EASDiabetes
EASD 2024: Insights on Heart Failure with Preserved Ejection Fraction (HFpEF)  @EASDiabetes
Uploaded November 2024 | Updated September 2026, 3 days ago
In this EASD TV interview, experts discuss the rising prevalence of heart failure with preserved ejection fraction (HFpEF), particularly in patients with diabetes and obesity. Dr. Melanie Davies, Dr. Mark Petrie, and Dr. Mikhail Kosiborod delve into the latest trial results, highlighting the impact of treatments like stide on heart failure symptoms, weight loss, and diabetes management. This video provides valuable insights for both cardiologists and diabetologists working with patients affected by HFpEF, offering guidance on treatment options and future research directions.

#HFpEF #HeartFailure #EASD2024 #DiabetesCare #Cardiology #Diabetology #HeartHealth #Obesity #Type2Diabetes #MedicalResearch #DiabetesManagement #StideTrial
EASD 2024: Insights on Heart Failure with Preserved Ejection Fraction (HFpEF)Meet the EASD Early Career Academy - Introducing Ilke SenEASD 2025: Is Type 1 Diabetes a Slow Virus Disease?EASD 2024 - What Will the Future Bring for People Living with Diabetes?EASD 2023 - Interview with Carel Le Roux about bariatric surgery and weight lowering drugsMeet the EASD Early Career Academy - Introducing: Jan GojdaEASD 2025: Whats the Methodology behind a Clinical Guideline?EASD 2023 - Eelco de Koning discusses pancreas and islet transplantationEASD 2025: Everything you Want to Know about Adipose Tissue#EASD2022 Interview with Christian Wolfrum and Kirsi Virtanen on Brown BatEASD 2025: SURPASSing Therapeutic Challenges of Paediatric T2D with TirzepatideEASD 2023 - Richard David Leslie about different presentations of type 1 diabetes
European Association for the Study of Diabetes |

EASD 2024: Insights on Heart Failure with Preserved Ejection Fraction (HFpEF)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER